Toll Free: 1-888-928-9744

Narcolepsy Global Clinical Trials Review, H1, 2016

Published: Apr 20, 2016 | Pages: 71 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Narcolepsy Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, "Narcolepsy Global Clinical Trials Review, H1, 2016" provides an overview of Narcolepsy clinical trials scenario. This report provides top line data relating to the clinical trials on Narcolepsy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 3 Report Guidance 4 Clinical Trials by Region 5 Clinical Trials and Average Enrollment by Country 6 Top Countries Contributing to Clinical Trials in Asia-Pacific 8 Top Five Countries Contributing to Clinical Trials in Europe 9 Top Countries Contributing to Clinical Trials in North America 10 Top Countries Contributing to Clinical Trials in Middle East and Africa 11 Clinical Trials by G7 Countries: Proportion of Narcolepsy to Central Nervous System Clinical Trials 12 Clinical Trials by Phase in G7 Countries 13 Clinical Trials in G7 Countries by Trial Status 14 Clinical Trials by E7 Countries: Proportion of Narcolepsy to Central Nervous System Clinical Trials 15 Clinical Trials by Phase in E7 Countries 16 Clinical Trials by Phase 17 In Progress Trials by Phase 18 Clinical Trials by Trial Status 19 Clinical Trials by End Point Status 20 Subjects Recruited Over a Period of Time 21 Clinical Trials by Sponsor Type 22 Prominent Sponsors 23 Top Companies Participating in Narcolepsy Therapeutics Clinical Trials 24 Prominent Drugs 26 Latest Clinical Trials News on Narcolepsy 27 Mar 31, 2016: Flamel Technologies Files Special Protocol Assessment for Once Nightly Sodium Oxybate 27 Mar 30, 2016: Theranexus: Preclinical Results Published in the Specialist Medical Journal Sleep 27 Clinical Trial Profile Snapshots 28 Appendix 68 Abbreviations 68 Definitions 68 Research Methodology 69 Secondary Research 69 About GlobalData 70 Contact Us 70 Disclaimer 70 Source 71
List of Tables
Narcolepsy Therapeutics, Global, Clinical Trials by Region, 2016* 5 Narcolepsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6 Narcolepsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7 Narcolepsy Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 8 Narcolepsy Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 9 Narcolepsy Therapeutics Clinical Trials, North America, Top Countries, 2016* 10 Narcolepsy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 11 Proportion of Narcolepsy to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 12 Narcolepsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13 Narcolepsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14 Proportion of Narcolepsy to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 15 Narcolepsy Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 16 Narcolepsy Therapeutics, Global, Clinical Trials by Phase, 2016* 17 Narcolepsy Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 18 Narcolepsy Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19 Narcolepsy Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20 Narcolepsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21 Narcolepsy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 22 Narcolepsy Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23 Narcolepsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 25 Narcolepsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 26


List of Figures
Narcolepsy Therapeutics, Global, Clinical Trials by Region (%), 2016* 5 Narcolepsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6 Narcolepsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7 Narcolepsy Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 8 Narcolepsy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 9 Narcolepsy Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 10 Proportion of Narcolepsy to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 12 Narcolepsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13 Narcolepsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14 Proportion of Narcolepsy to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 15 Narcolepsy Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 16 Narcolepsy Therapeutics, Global, Clinical Trials by Phase (%), 2016* 17 Narcolepsy Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 18 Narcolepsy Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19 Narcolepsy Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20 Narcolepsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21 Narcolepsy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 22 Narcolepsy Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23 Narcolepsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 24 Narcolepsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 26 GlobalData Methodology 69

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global amino acids market size is anticipated to be valued at USD 35.4 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in animal feed additive demand owing to regulate metabolism in livestock production owing to growi

Read More...

Global automotive coatings market size is likely to be valued at USD 27.7 billion by 2022; as per a new research report by Radiant Insights, Inc. Vehicle aesthetics, UV radiation and temperature variation protection and enhance durability are certain

Read More...

Global advanced energy storage systems market size is anticipated to be valued at USD 24.8 billion by 2022, as per a new research report by Radiant Insights, Inc. Increasing energy consumption coupled with strong energy demand for industrial, commerc

Read More...

Global sorbitol market size is anticipated to be reach USD 3.99 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing consumer perception towards product benefits derived from natural ingredients is expected to drive the dem

Read More...

Global automotive relay market is anticipated to reach USD 12 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising need for high-frequency signals in automotive industry is expected to drive demand. These relays enhance driv

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify